In Segment A, individuals will get various doses and schedules of oral ABBV-744 tablet to detect Protected dosing routine. Supplemental individuals might be enrolled on the determined monotherapy dosign program. In Section B, contributors will acquire oral ruxolitinib and ABBV-744 will likely be supplied as "add-on" therapy. In Segment C, https://baltasarz211lwi4.rimmablog.com/profile